179 related articles for article (PubMed ID: 22140521)
21. Strain-specific duffy binding protein antibodies correlate with protection against infection with homologous compared to heterologous plasmodium vivax strains in Papua New Guinean children.
Cole-Tobian JL; Michon P; Biasor M; Richards JS; Beeson JG; Mueller I; King CL
Infect Immun; 2009 Sep; 77(9):4009-17. PubMed ID: 19564376
[TBL] [Abstract][Full Text] [Related]
22. Plasmodium vivax pre-erythrocytic-stage antigen discovery: exploiting naturally acquired humoral responses.
Molina DM; Finney OC; Arevalo-Herrera M; Herrera S; Felgner PL; Gardner MJ; Liang X; Wang R
Am J Trop Med Hyg; 2012 Sep; 87(3):460-9. PubMed ID: 22826492
[TBL] [Abstract][Full Text] [Related]
23. Asymptomatic Plasmodium vivax infections induce robust IgG responses to multiple blood-stage proteins in a low-transmission region of western Thailand.
Longley RJ; França CT; White MT; Kumpitak C; Sa-Angchai P; Gruszczyk J; Hostetler JB; Yadava A; King CL; Fairhurst RM; Rayner JC; Tham WH; Nguitragool W; Sattabongkot J; Mueller I
Malar J; 2017 Apr; 16(1):178. PubMed ID: 28454546
[TBL] [Abstract][Full Text] [Related]
24. Naturally Acquired Binding-Inhibitory Antibodies to Plasmodium vivax Duffy Binding Protein and Clinical Immunity to Malaria in Rural Amazonians.
Nicolete VC; Frischmann S; Barbosa S; King CL; Ferreira MU
J Infect Dis; 2016 Nov; 214(10):1539-1546. PubMed ID: 27578850
[TBL] [Abstract][Full Text] [Related]
25. Blood-stage Plasmodium vivax antibody dynamics in a low transmission setting: A nine year follow-up study in the Amazon region.
Pires CV; Alves JRS; Lima BAS; Paula RB; Costa HL; Torres LM; Sousa TN; Soares IS; Sanchez BAM; Fontes CJF; Ntumngia FB; Adams JH; Kano FS; Carvalho LH
PLoS One; 2018; 13(11):e0207244. PubMed ID: 30419071
[TBL] [Abstract][Full Text] [Related]
26. Parasite density and serum cytokine levels in Plasmodium vivax malaria in Turkey.
Zeyrek FY; Kurcer MA; Zeyrek D; Simsek Z
Parasite Immunol; 2006 May; 28(5):201-7. PubMed ID: 16629705
[TBL] [Abstract][Full Text] [Related]
27. IgG antibodies to synthetic GPI are biomarkers of immune-status to both Plasmodium falciparum and Plasmodium vivax malaria in young children.
França CT; Li Wai Suen CSN; Carmagnac A; Lin E; Kiniboro B; Siba P; Schofield L; Mueller I
Malar J; 2017 Sep; 16(1):386. PubMed ID: 28946883
[TBL] [Abstract][Full Text] [Related]
28. Sero-epidemiological evaluation of changes in Plasmodium falciparum and Plasmodium vivax transmission patterns over the rainy season in Cambodia.
Cook J; Speybroeck N; Sochanta T; Somony H; Sokny M; Claes F; Lemmens K; Theisen M; Soares IS; D'Alessandro U; Coosemans M; Erhart A
Malar J; 2012 Mar; 11():86. PubMed ID: 22443375
[TBL] [Abstract][Full Text] [Related]
29. Plasmodium vivax Duffy binding protein: baseline antibody responses and parasite polymorphisms in a well-consolidated settlement of the Amazon Region.
Kano FS; Sanchez BA; Sousa TN; Tang ML; Saliba J; Oliveira FM; Nogueira PA; Gonçalves AQ; Fontes CJ; Soares IS; Brito CF; Rocha RS; Carvalho LH
Trop Med Int Health; 2012 Aug; 17(8):989-1000. PubMed ID: 22643072
[TBL] [Abstract][Full Text] [Related]
30. Humoral immune responses against the malaria vaccine candidate antigen Plasmodium vivax AMA-1 and IL-4 gene polymorphisms in individuals living in an endemic area of the Brazilian Amazon.
Tomaz FM; da Cruz Furini AA; Capobianco MP; Póvoa MM; Trindade PC; Fraga VD; Conceição LM; de Azevedo LR; Oliani SM; Cassiano GC; Cavasini CE; Dos Santos SE; Machado RL
Cytokine; 2015 Aug; 74(2):273-8. PubMed ID: 25922277
[TBL] [Abstract][Full Text] [Related]
31. Immune response to Plasmodium vivax has a potential to reduce malaria severity.
Chuangchaiya S; Jangpatarapongsa K; Chootong P; Sirichaisinthop J; Sattabongkot J; Pattanapanyasat K; Chotivanich K; Troye-Blomberg M; Cui L; Udomsangpetch R
Clin Exp Immunol; 2010 May; 160(2):233-9. PubMed ID: 20030672
[TBL] [Abstract][Full Text] [Related]
32. Unexpected high circulation of Plasmodium vivax in asymptomatic children from Kédougou, southeastern Senegal.
Niang M; Diop F; Niang O; Sadio BD; Sow A; Faye O; Diallo M; Sall AA; Perraut R; Toure-Balde A
Malar J; 2017 Dec; 16(1):497. PubMed ID: 29284488
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of a serological tool to predict malaria transmission intensity in an elimination setting.
Dewasurendra RL; Dias JN; Sepulveda N; Gunawardena GS; Chandrasekharan N; Drakeley C; Karunaweera ND
BMC Infect Dis; 2017 Jan; 17(1):49. PubMed ID: 28068925
[TBL] [Abstract][Full Text] [Related]
34. Sparse serological evidence of Plasmodium vivax transmission in the Ouest and Sud-Est departments of Haiti.
Weppelmann TA; von Fricken ME; Lam B; Telisma T; Existe A; Lemoine JF; Larkin J; Okech BA
Acta Trop; 2016 Oct; 162():27-34. PubMed ID: 27230796
[TBL] [Abstract][Full Text] [Related]
35. Naturally Acquired Antibody Response to Malaria Transmission Blocking Vaccine Candidate Pvs230 Domain 1.
Tentokam BCN; Amaratunga C; Alani NAH; MacDonald NJ; Narum DL; Salinas ND; Kwan JL; Suon S; Sreng S; Pereira DB; Tolia NH; Fujiwara RT; Bueno LL; Duffy PE; Coelho CH
Front Immunol; 2019; 10():2295. PubMed ID: 31636633
[No Abstract] [Full Text] [Related]
36. Characterizing Antibody Responses to Plasmodium vivax and Plasmodium falciparum Antigens in India Using Genome-Scale Protein Microarrays.
Uplekar S; Rao PN; Ramanathapuram L; Awasthi V; Verma K; Sutton P; Ali SZ; Patel A; G SL; Ravishankaran S; Desai N; Tandel N; Choubey S; Barla P; Kanagaraj D; Eapen A; Pradhan K; Singh R; Jain A; Felgner PL; Davies DH; Carlton JM; Das J
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005323. PubMed ID: 28118367
[TBL] [Abstract][Full Text] [Related]
37. IgG antibody profile to c-terminal region of Plasmodium vivax merozoite surface protein-1 in Thai individuals exposed to malaria.
Pitabut N; Panichakorn J; Mahakunkijcharoen Y; Hirunpetcharat C; Looareesuwan S; Khusmith S
Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):1-7. PubMed ID: 17539238
[TBL] [Abstract][Full Text] [Related]
38. Geographical patterns of malaria transmission based on serological markers for falciparum and vivax malaria in Ratanakiri, Cambodia.
Kerkhof K; Sluydts V; Heng S; Kim S; Pareyn M; Willen L; Canier L; Sovannaroth S; Ménard D; Sochantha T; Coosemans M; Durnez L
Malar J; 2016 Oct; 15(1):510. PubMed ID: 27756395
[TBL] [Abstract][Full Text] [Related]
39. Naturally acquired antibodies to Plasmodium vivax blood-stage vaccine candidates (PvMSP-1₁₉ and PvMSP-3α₃₅₉₋₇₉₈ and their relationship with hematological features in malaria patients from the Brazilian Amazon.
Mourão LC; Morais CG; Bueno LL; Jimenez MC; Soares IS; Fontes CJ; Guimarães Lacerda MV; Xavier MS; Barnwell JW; Galinski MR; Braga EM
Microbes Infect; 2012 Aug; 14(9):730-9. PubMed ID: 22445906
[TBL] [Abstract][Full Text] [Related]
40. [Characterization of Plasmodium vivax malaria transmission at the border of Panamá and Costa Rica].
Cáceres L; Rovira J; Torres R; García A; Calzada J; De La Cruz M
Biomedica; 2012; 32(4):557-69. PubMed ID: 23715231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
